Target intelligence / Profile preview

Excitatory amino acid transporter 3 or Excitatory amino acid transporter 4 (EAAT3 / EAAT4)

Target
EAAT3 / EAAT4
Molecular classification
Transporter, Solute carrier family (SLC1), Excitatory amino acid transporter
01

Overview

Excitatory amino acid transporters 3 (EAAT3, SLC1A1) and 4 (EAAT4, SLC1A6) are sodium-dependent, high-affinity glutamate transporters belonging to the solute carrier family 1 (SLC1)[6][7]. EAAT3 is primarily expressed in neurons throughout the CNS, particularly in hippocampus, striatum, and cerebellum, while EAAT4 is predominantly localized to cerebellar Purkinje cells[6][5][1]. Both play essential roles in clearing extracellular glutamate from the synaptic cleft and limiting spillover to extrasynaptic receptors, thereby regulating excitatory neurotransmission and protecting against excitotoxicity[5][3][6]. EAAT3 is also unique in its efficient transport of L-cysteine, supporting glutathione synthesis and redox balance[2]. Loss-of-function mutations in EAAT3 cause dicarboxylic aminoaciduria, while dysfunction or altered expression of EAAT3/EAAT4 is implicated in neurodegenerative and psychiatric diseases[4][6]. Both transporters operate as trimeric complexes with characteristic transmembrane topology and may also exhibit anion channel activity[1][5][7].

Other names
EAAT3 (also known as EAAC1, SLC1A1)EAAT4 (also known as SLC1A6)
02

Mechanism of action

Increased transporter expression or function reduces extracellular glutamate and protects from excitotoxicity; blockade or mutation impairs glutamate uptake and increases synaptic glutamate[4][6]

03

Biological functions

Glutamate reuptakeAspartate transportCysteine transport (EAAT3)Regulation of excitatory neurotransmissionProtection against excitotoxicityAmino acid metabolismRedox homeostasis (EAAT3)Removal of glutamate from synaptic cleft
04

Disease associations

Neurodegenerative diseaseNeuropsychiatric disordersEpilepsyDicarboxylic aminoaciduria (EAAT3)SchizophreniaCognitive dysfunctionOther CNS disorders
05

Safety considerations

Targeting EAAT3/EAAT4 directly poses risk for altering excitatory neurotransmission, which can result in neurotoxicity or neurological side effectseffects may vary between brain regions[4][6]
06

Interacting drugs

Ceftriaxone (indirect upregulation)

2 more in the full profile.

07

Biomarkers

Loss-of-function mutations in SLC1A1 (EAAT3) are biomarkers for dicarboxylic aminoaciduriatransporter expression levels may serve as markers in CNS disease and injury[4][6]

Beyond the preview

Go deeper on Excitatory amino acid transporter 3 or Excitatory amino acid transporter 4 (EAAT3 / EAAT4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Excitatory amino acid transporter 3 or Excitatory amino acid transporter 4 (EAAT3 / EAAT4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call